Abbas El Sahili is the Chief Executive Officer of Singzyme, a biotechnology company that provides enzymatic conjugation using Peptide Asparaginyl Ligases. He has a Ph.D. in Biochemistry and Structural Biology and has published 30 research papers. He is also a Senior Research Fellow at the Nanyang Technological University in Singapore.
Abbas El Sahili’s research career has been focused on biochemistry and structural biology. He has worked on projects such as the purification of Dengue and Zika Virus Non-structural Protein 5 for Crystallization and Screening of Antivirals. He pursued his research work on Peptide Asparaginyl Ligases using biochemistry techniques, protein engineering and X-ray crystallography to uncover the detailed molecular mechanism of these enzymes and use them to produce novel biologics.
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.